Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2003
09/23/2003US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same
09/23/2003US6623937 Programmed cell death antagonist protein
09/23/2003US6623934 For isolation of proteins that may be used to induce bone and/or cartilage or other connective tissue formation, and in wound healing and tissue repair
09/23/2003US6623933 Methods for identifying a subunit specific modulator of N-methyl-D-asparate receptor
09/23/2003US6623931 Diagnostic assay for antibiotic tolerance
09/23/2003US6623929 Reacting polymerase with a substrate; modulating the conformation of the polymerase by applying monochromatic light to allow incorporation of the nucleotide; bacteriorhodopsin
09/23/2003US6623926 Methods for producing 5′-nucleic acid-protein conjugates
09/23/2003US6623925 Screening for a test compound that affects the ability of DNA to bind to protein or affects the expression of reporter molecule; use for gene therapy
09/23/2003US6623924 Method for determining susceptibility to rheumatoid arthritis
09/23/2003US6623923 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
09/23/2003US6623741 Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission
09/23/2003US6623740 Peptide having an amino acid sequence set forth in SEQ ID NO: 3, 5, 9, 11, 13, 14 or 15
09/23/2003US6623738 Polypeptide consisting of amino acid sequence 2 or 4 which is not cross reactive with mouse, chick nor drosophila neuro-pilin-1
09/23/2003US6623737 Epitopes; medical diagnosis
09/23/2003US6623472 Method for inducing therapeutically-effective proteins
09/23/2003CA2164818C Tandem synthetic hiv-1 peptides
09/23/2003CA2147482C Process for manufacturing crystals of growth hormone and crystals thereby obtained
09/23/2003CA2139632C Assay for chagas' disease and reagents for its use
09/23/2003CA2139518C Antigenic regions of tlp complexes and antibodies against the same
09/23/2003CA2113477C Yeast strains with stable integration of heterologous genes
09/23/2003CA2113099C Differentiation of htlv-i and htlv-ii using synthetic peptides
09/23/2003CA2112907C Peptide which abrogates tnf and/or lps toxicity
09/23/2003CA2091651C Agent for suppresion and interception of mailard reaction
09/23/2003CA2082424C Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
09/23/2003CA1341439C Feline t-lymphotropic lentivirus
09/21/2003CA2378089A1 Spatial learning and memory
09/18/2003WO2003076950A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
09/18/2003WO2003076948A1 Use of the mal protein as a tumour marker
09/18/2003WO2003076944A1 Annotation of genome sequences
09/18/2003WO2003076936A1 Method of preparing a protein array based on biochemical protein-protein interaction
09/18/2003WO2003076898A2 Mycobacterial diagnostics
09/18/2003WO2003076658A2 A susceptibility gene for late-onset idiopathic parkinson's disease
09/18/2003WO2003076647A2 Jade nucleic acids, proteins and uses thereof
09/18/2003WO2003076646A2 Identification and tissue distribution of two novel spliced variants of the mouse lats2 gene
09/18/2003WO2003076645A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/18/2003WO2003076644A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/18/2003WO2003076643A2 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections
09/18/2003WO2003076642A2 Novel proteins and nucleic acids encoding same
09/18/2003WO2003076636A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
09/18/2003WO2003076634A2 Transcriptional regulation of ptp-1b
09/18/2003WO2003076632A1 Novel method for the production of hybrid maize seeds
09/18/2003WO2003076631A2 Genetic products differentially expressed in tumors and use thereof
09/18/2003WO2003076627A1 Process for the preparation of l-amino acids using strains of the family enterobacteriaceae
09/18/2003WO2003076626A1 Gene participating in the synthesis of brassinosteroid
09/18/2003WO2003076625A1 Proteolysis resistant active vegf
09/18/2003WO2003076622A1 PRESYNAPTIC PROTEIN p120
09/18/2003WO2003076617A1 Transporter selectively transporting sulfate conjugate and its gene
09/18/2003WO2003076614A1 Method of collecting data for deducing sensitivity to periodontal disease
09/18/2003WO2003076613A1 Protein sustaining undifferentiated stem cells as such
09/18/2003WO2003076612A1 Method of repressing flowering in a plant
09/18/2003WO2003076603A2 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
09/18/2003WO2003076598A2 Method of inducing an enhanced immune response against hiv
09/18/2003WO2003076597A2 Nucleic acid sequences encoding the bos1 gene and promoter from arabidopisis thaliana and uses thereof
09/18/2003WO2003076596A2 Altering viral tropism
09/18/2003WO2003076595A2 Production of insulin and insulin-like proteins in plants
09/18/2003WO2003076591A2 Compositions and methods for generating an immune response
09/18/2003WO2003076590A2 Arrestin gene, polypeptide and methods of use thereof
09/18/2003WO2003076587A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076586A2 Nucleic acid-associated proteins
09/18/2003WO2003076585A2 Controlled modulation of amino acid side chain length of peptide antigens
09/18/2003WO2003076584A2 Novel proteins and nucleic acids encoding same
09/18/2003WO2003076579A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076578A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/18/2003WO2003076575A2 The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof
09/18/2003WO2003076573A2 Quantitative trait loci and somatostatin
09/18/2003WO2003076571A2 Cancer-linked gene as target for chemotherapy
09/18/2003WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
09/18/2003WO2003076567A2 Heterologous g-csf fusion proteins
09/18/2003WO2003076563A2 Human protooncogene and protein encoded therein
09/18/2003WO2003076561A2 Recombinase fusion protein with enhanced cellular uptake
09/18/2003WO2003076470A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
09/18/2003WO2003076468A1 Novel therapeutic composition for the prevention and treatment of hiv-1 infection in humans
09/18/2003WO2003076467A1 Compositions and methods for inducing and regulating bone formation
09/18/2003WO2003076466A1 Enhanced inserted yellow fluorescence protein and its application
09/18/2003WO2003076464A2 Mutagenesis of aspergillus fungi and identification of genes essential for growth
09/18/2003WO2003076463A2 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance
09/18/2003WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides
09/18/2003WO2003076455A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
09/18/2003WO2003076365A2 Materials and methods for controlling pests
09/18/2003WO2003075960A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
09/18/2003WO2003075956A2 Use of mixtures of lipopeptides for vaccine production
09/18/2003WO2003075955A1 Method for enhancing immune responses by codelivering influenza np dna in dna immunization
09/18/2003WO2003075952A1 Methods of enhancing immune induction involving mda-7
09/18/2003WO2003075950A1 Minimising body weight gain in insulin treatment
09/18/2003WO2003075945A2 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
09/18/2003WO2003075944A2 Interferon beta-like molecules for treatment of stroke
09/18/2003WO2003075849A2 Composition and method for enhancing immune response
09/18/2003WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/18/2003WO2003075845A2 Immunogenicity of glucan binding protein
09/18/2003WO2003075843A2 Multiple and multivalent dna vaccines in ovo
09/18/2003WO2003075841A2 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
09/18/2003WO2003075831A2 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME
09/18/2003WO2003075790A2 Gas-plasma treatment of implants
09/18/2003WO2003075655A2 Novel vip3 toxins and methods of use
09/18/2003WO2003075647A2 Method and system for in vivo analysis of developmental processes
09/18/2003WO2003068815A3 Mhc class ii peptide epitope of 5t4 antigen
09/18/2003WO2003061570A3 Engineered binding proteins
09/18/2003WO2003060068A3 Oxa1p enhanced protein secretion
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
1 ... 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 ... 2916